These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15548698)

  • 1. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.
    Oh A; List HJ; Reiter R; Mani A; Zhang Y; Gehan E; Wellstein A; Riegel AT
    Cancer Res; 2004 Nov; 64(22):8299-308. PubMed ID: 15548698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.
    Ochnik AM; Peterson MS; Avdulov SV; Oh AS; Bitterman PB; Yee D
    Neoplasia; 2016 Feb; 18(2):100-10. PubMed ID: 26936396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.
    Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J
    Cancer Res; 2004 Mar; 64(5):1875-85. PubMed ID: 14996752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.
    List HJ; Lauritsen KJ; Reiter R; Powers C; Wellstein A; Riegel AT
    J Biol Chem; 2001 Jun; 276(26):23763-8. PubMed ID: 11328819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1.
    Anzick SL; Azorsa DO; Simons SS; Meltzer PS
    BMC Cancer; 2003 Sep; 3():22. PubMed ID: 12964942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
    Lahusen T; Fereshteh M; Oh A; Wellstein A; Riegel AT
    Cancer Res; 2007 Aug; 67(15):7256-65. PubMed ID: 17671194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3K and AIB1 interaction is involved in estrogen treated breast cancer cells.
    Li Z; Deng X; Wu G; Qiu R; Ju X; Wang Y; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):65-70. PubMed ID: 29808803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
    Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
    Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
    Lauritsen KJ; List HJ; Reiter R; Wellstein A; Riegel AT
    Oncogene; 2002 Oct; 21(47):7147-55. PubMed ID: 12370804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
    Ravid D; Maor S; Werner H; Liscovitch M
    Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
    Varma H; Conrad SE
    Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
    Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
    Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
    Lassarre C; Ricort JM
    Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
    Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
    J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231).
    Elumalai P; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
    Cell Biochem Funct; 2014 Jul; 32(5):476-84. PubMed ID: 24888707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
    Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT
    Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.